|
gptkbp:instanceOf
|
gptkb:law
European company
|
|
gptkbp:abbreviation
|
SE
|
|
gptkbp:allows
|
transfer of registered office between EU member states
|
|
gptkbp:boardStructure
|
two-tier
one-tier
|
|
gptkbp:category
|
gptkb:company
gptkb:public_company
corporate law
|
|
gptkbp:employeeParticipation
|
required
|
|
gptkbp:enables
|
cross-border business
|
|
gptkbp:establishedBy
|
gptkb:Council_Regulation_(EC)_No_2157/2001
|
|
gptkbp:form
|
merger of public limited companies from different EU states
conversion of a public limited company
creation of a holding SE
creation of a subsidiary SE
|
|
gptkbp:governedBy
|
EU law
national law of member state of registration
|
|
gptkbp:headquarters
|
within the European Economic Area
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Societas Europaea (SE)
|
|
gptkbp:jurisdiction
|
gptkb:European_Union
|
|
gptkbp:language
|
gptkb:Latin
|
|
gptkbp:minimumInvestment
|
€120,000
|
|
gptkbp:purpose
|
facilitate cross-border operations in the EU
|
|
gptkbp:regulates
|
gptkb:European_Parliament
|
|
gptkbp:relatedTo
|
gptkb:public_company
gptkb:Societas_Privata_Europaea_(SPE)
Aktiengesellschaft (AG)
|
|
gptkbp:startDate
|
8 October 2004
|
|
gptkbp:translatedInto
|
gptkb:European_Company
|
|
gptkbp:bfsParent
|
gptkb:Allianz
gptkb:BioNTech
|
|
gptkbp:bfsLayer
|
5
|